Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
short-term radiotherapy
RADIATION
2 trials
Sponsors
Fudan University
, Nanfang Hospital, Southern Medical University
Conditions
High-Risk
Locally Advanced
Locally Advanced Colon Cancer
MSS
Rectal Cancer
Phase 2
Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)
NCT05732493
Fudan University
Locally Advanced Colon Cancer
Start: 2023-03-01
End: 2024-12-31
Target: 120
Updated: 2023-02-17
Unknown Phase
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Recruiting
NCT05877573
Nanfang Hospital, Southern Medical University
High-Risk, Locally Advanced, MSS +1
Start: 2023-07-01
End: 2026-08-01
Target: 53
Updated: 2023-07-05
Related Papers
Neoadjuvant immunotherapy combined with radiochemotherapy vs chemotherapy alone in pMMR colon cancers: The TORCH-C randomized phase 2 clinical trial.
Journal of Clinical Oncology
2026-05-27
Neoadjuvant short-course radiotherapy combined with CAPOX and PD-1 inhibitor for MSS/pMMR high-risk locally advanced colon cancer: A randomized, prospective, multicentre, phase II trial (TORCH-C).
Journal of Clinical Oncology
2026-01-10
Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C)
BMJ Open
2024-02-01
5 citations